05016nam a2200445zi 45000010014000000030008000140050017000220070015000390080041000540200028000950200025001230220014001480400031001620720016001930720015002090720015002242450078002392640054003173360021003713370023003923380032004153650110004473660044005574900036006015000047006375051055006845160013017395200986017525451436027386500034041746500033042086500033042417000033042747000026043077000036043337000029043697000034043988560066044328560072044989781849841290UK-WkNB20200221000000.0cu||||||||||||200221e202101uuxxk |s|||||||0|0 eng|d a9781849841290 :c$85.00 a1849841292 :c$85.00 a2312-5098 aUK-WkNBbengcUK-WkNBerda 7aMJL2bicssc 7aHEA2ukslc 7aMJL2thema10aSupporting Tobacco Cessation /cEdited by Sofia Belo Ravara [and others]. 1aSheffield :bEuropean Respiratory Society,c2021. atext2rdacontent acomputer2rdamedia aonline resource2rdacarrier a02b85.00cUSDd00eThis price includes a tax elementhZ 85.00 0.00 85.00 0.00jGBkxxkmTEDITOR2onix-pt b20210101cIP 20210101jGBkxxk2UK-WkNB0 aERS Monograph,x2312-5098 ;v90 aElectronic book text. Text (eye-readable).0 aTobacco is still the most important preventable cause of respiratory diseases-- Understanding nicotine addiction and the health effects of nicotine use-- E-cigarettes, heated tobacco and other novel nicotine-containing products: a help to smokers or a public health threat? Practical guidance on the use of motivational interviewing to support behaviour change-- Behaviour counselling and psychosocial interventions. The role of patient involvement-- Evidence of the effectiveness and safety of first-line smoking cessation pharmacotherapy-- Optimising health systems to deliver tobacco-dependence treatment-- Asthmatic patients-- COPD patients-- Lung cancer patients-- Tuberculosis patients-- Patients living with other respiratory diseases-- Cardiovascular patients-- Patients with common endocrine disorders-- "It's the one thing they have left": smoking, smoking cessation and mental health-- Preventing tobacco use and exposure to second-hand tobacco smoke in pregnancy-- Preventing the initiation of tobacco and e-cigarette use among the youth. aDocument aA comprehensive overview of tobacco cessation, from health policy to patient care, which also deals with some of the more controversial topics such as e-cigarettes and web applications.bThis Monograph provides a comprehensive overview of tobacco cessation, from health policy to patient care. Broad in scope, this state-of-the art collection is broken down into four sections: the changing landscape of the tobacco epidemic and challenges to curb it; treatment of tobacco dependence (pharmacotherapy, behavioural support); improving the care of patients with particular conditions who smoke (asthma, COPD, TB, cardiovascular diseases, etc.); and prevention. It also deals with some of the more controversial topics such as e-cigarettes and web applications. Readers will gain an understanding of how to implement smoking cessation into their everyday practice, but will also expand their knowledge about the policy and systems changes needed for population-wide smoking cessation.0 aSofia Belo Ravara is Consultant of Pulmonology and Assistant Professor of Preventive Medicine and Epidemiology at the University Hospital/University of Beira Interior, Covilha, Portugal. She is also associate researcher at the National School of Public Health, NOVA University, Lisbon, Portugal. Between 2000 and 2010, Elif Dagli worked as Chair of the Department of Paediatrics and Head of Paediatric Pulmonology at Marmara University Hospital (Istanbul, Turkey). She lectures on the health effects of tobacco, nicotine and novel products, tobacco control strategies, chronic lung disease of childhood, differential diagnoses by respiratory symptoms, cystic fibrosis and tuberculosis. Paraskevi Katsaounou is Assistant Professor of Respiratory Medicine at the National and Kapodistrian University of Athens Medical School (NKUA) (Athens, Greece) and does clinical work at the Pulmonary and Respiratory Failure Department of the first ICU of Evangelismos Hospital (Athens, Greece). Keir E. Lewis is a Professor at Swansea University (Swansea, UK) and Respiratory Lead for a group of hospitals (Hywel Dda University Health Board) in Wales, UK. Charlotta Pisinger is a medical doctor, has a PhD and a masters in public health and is Denmark's first professor in tobacco prevention. She is a Professor at the University of Copenhagen (Copenhagen, Denmark) and Adjunct Professor at the University of Southern Denmark (Odense, Denmark). 7aRespiratory medicine.2bicssc 7aHealth and Wellbeing.2ukslc 7aRespiratory medicine.2thema1 aBelo Ravara, Sofia,eeditor.1 aDagli, Elif,eeditor.1 aKatsaounou, Paraskevi,eeditor.1 aE. Lewis, Keir,eeditor.1 aPisinger, Charlotta,eeditor.4 uhttp://www.ersbookshop.comx01zPublisher's corporate website4 uhttp://www.books.ersjournals.comx01zPublisher's corporate website